2026 Q1 -tulosraportti
Vain PDF
98 päivää sitten
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. | 7 päivää |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·2 t sitten · MuokattuStock status Everything is status quo, so we can conclude that it has not yet been possible to get the oil into Germany. But as long as Germany is not completely dry, people can get hold of the oil when they get a prescription. The following is on my bill. I'm crossing my fingers that Weeco Pharma will manage to get the oil into Germany before the people who have hoarded a small stock of flower medicine privately run out. The people who hoarded this summer have been able to buy 100 grams per month. Around 200 grams in total. How long will it take them to smoke/vape 200 grams of cannabis 2-3 months? As these stocks run out, they will go to their doctor to get a prescription for an alternative cannabis medicine to the flower medicine. Weeco Astrum 10/10 is not affected by a 6-month quarantine, and the product has retained 100% reimbursement, and therefore doctors can calmly (the feared Regress system) prescribe Weeco Astrum 10/10 to patients where doctors assess that they should have a prescription for Weeco Astrum 10/10. If my little unscientific calculation is correct, Weeco Pharma has a couple of months to run on, so I guess they will make it. It says approximately in the middle of the article and under the heading How exactly is cannabis prescribed? https://www.aerzteblatt.de/archiv/medizinisches-cannabis-die-wichtigsten-aenderungen-8947932a-bc22-401b-a928-ee432de6bc59I just have an addition to the above. It occurred to me that I have read somewhere that it was also changed that people now have to meet with their general practitioner to get a prescription for medical cannabis. Telemedicine is forbidden (if I have understood it correctly, it is a complicated topic) A maximum of (at most) 3 months may pass before a doctor sees their patient with a chronic illness, which again means that the doctor may at most prescribe a prescription for medical cannabis that lasts for 3 months. Previously, they could prescribe a prescription for Weeco Astrum 10/10 2 bottles of 30 ml. and people typically bought 2 bottles at a time. They can no longer do that, when one bottle typically lasts 2-3 months. https://www.hausaerztlichepraxis.digital/praxis/medikamente-fuer-mehrere-monate-auf-rezept-moeglich-127970.html- ·1 päivä sittenstock status All is status quo, but I can see that the pharmacy in Hamburg has many in stock, (dark green dot) but the pharmacy in Dusseldorf has few in stock. (light green dot) However, I cannot see the quantity. Bonus information As is known, I have been looking at stock status since May 13th. After legislation of July 10th, there was a state of chaos. What I have subsequently observed is that the flower medicine of different brands sold out and quickly came back in stock. But as the days went by, I could see that more and more online stores reported sold out, and the flowers did not come back in stock. I wondered about it, but I didn't think much more about it. (It wasn't the flower medicine I was keeping an eye on) It was only after July 29th, when it was announced that the flower medicine had its subsidy withdrawn, that the penny dropped. The German users have naturally hoarded flower medicine, just in case the politicians were serious about it. Those people who were proactive could manage to build up a private stock for at least 6 months' consumption. It has been a blessing in disguise for Stenocare that some of these 65,000 people, who now have to be converted to another product, have hoarded flower medicine. The misfortune consists in that those people who had not hoarded flower medicine, after July 30th, received a prescription for an oil preparation, including Weeco Astrum 10/10, and thereby a greater demand was created, which has led to bottlenecks. Because it all happened within a short period of time, neither Stenocare nor Weeco Pharma could react in time. Germany has very strict legislation regarding cannabis medicine, and that also applies to how much cannabis medicine one is allowed to have in stock. Therefore, it has not been possible for Weeco Pharma to build up a stock, in case this scenario should happen. The fortunate thing is that some people hoarded flower medicine before July 30th, and therefore not all 65,000 users have to be converted to another preparation within a very short period of time, and Germany would thus be completely drained of Weeco Astrum 10/10. I think that both Weeco Pharma and Stenocare have discovered the increased demand, and that more bottles are now being sent than were previously sent to Germany. To ensure that there is oil for everyone, as people's home stocks become empty, and they get a prescription for Weeco Astrum 10/10.Today's figures increase in number of trades 612% the price 0.932 kr. and the price has increased by 3.72%.
·1 päivä sittenIt seems some have tried to sell off a lot this past week, not least 100,000 units today. Can anyone see who is selling?- ·2 päivää sittenStock status Canngo: 2 pharmacies in Dusseldorf have bought the oil internally, and therefore have Weeco Astrum 10/10 back in stock. Weeco Pharma has not succeeded in getting a new batch approved, so they can restock the empty shelves again. I hope that will happen soon.I came across this article that has put numbers on how many people have lost their subsidy for flower medicine in Germany as of July 30. The article states 65,000 people. Although not all of them are prescribed Weeco Astrum 10/10, we can conclude that some of these people have received a prescription for Weeco Astrum 10/10 and this demand has led to bottlenecks in the delivery of the oil. Everyone who starts using Weeco Astrum 10/10 and it works as it should, will typically buy 4-6 bottles per year. https://internationalcbc.com/how-many-german-patients-are-impacted-by-cannabis-flower-changes/
·3 päivää sittenI have started doing deeper analysis coverage on the STENOCARE case, which I share via my new Substack (frees up space for the thread here, which from time to time becomes somewhat messy and unserious). Latest post – "STENOCARE: From growth case to maturity plateau – what Q1/Q2 data and the 14-day rates reveal before the Q2 report" – is located here: 👉 https://xcapitalinvestor.substack.com/p/stenocare-fra-vkstcase-til-modenhedsplateau The format is new to me, so feedback is very welcome – both on content and whether it creates value for you. Happy Monday ☕By the way, it's good that cash flow has developed positively, although the surplus is minimal. In that regard, the price pressure is a bit worrying (8% down, that is, so far). It won't take much further headwind before cash flow is red again, and purely financially, it's not as if Steno exactly has much to draw upon.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q1 -tulosraportti
Vain PDF
98 päivää sitten
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·2 t sitten · MuokattuStock status Everything is status quo, so we can conclude that it has not yet been possible to get the oil into Germany. But as long as Germany is not completely dry, people can get hold of the oil when they get a prescription. The following is on my bill. I'm crossing my fingers that Weeco Pharma will manage to get the oil into Germany before the people who have hoarded a small stock of flower medicine privately run out. The people who hoarded this summer have been able to buy 100 grams per month. Around 200 grams in total. How long will it take them to smoke/vape 200 grams of cannabis 2-3 months? As these stocks run out, they will go to their doctor to get a prescription for an alternative cannabis medicine to the flower medicine. Weeco Astrum 10/10 is not affected by a 6-month quarantine, and the product has retained 100% reimbursement, and therefore doctors can calmly (the feared Regress system) prescribe Weeco Astrum 10/10 to patients where doctors assess that they should have a prescription for Weeco Astrum 10/10. If my little unscientific calculation is correct, Weeco Pharma has a couple of months to run on, so I guess they will make it. It says approximately in the middle of the article and under the heading How exactly is cannabis prescribed? https://www.aerzteblatt.de/archiv/medizinisches-cannabis-die-wichtigsten-aenderungen-8947932a-bc22-401b-a928-ee432de6bc59I just have an addition to the above. It occurred to me that I have read somewhere that it was also changed that people now have to meet with their general practitioner to get a prescription for medical cannabis. Telemedicine is forbidden (if I have understood it correctly, it is a complicated topic) A maximum of (at most) 3 months may pass before a doctor sees their patient with a chronic illness, which again means that the doctor may at most prescribe a prescription for medical cannabis that lasts for 3 months. Previously, they could prescribe a prescription for Weeco Astrum 10/10 2 bottles of 30 ml. and people typically bought 2 bottles at a time. They can no longer do that, when one bottle typically lasts 2-3 months. https://www.hausaerztlichepraxis.digital/praxis/medikamente-fuer-mehrere-monate-auf-rezept-moeglich-127970.html
- ·1 päivä sittenstock status All is status quo, but I can see that the pharmacy in Hamburg has many in stock, (dark green dot) but the pharmacy in Dusseldorf has few in stock. (light green dot) However, I cannot see the quantity. Bonus information As is known, I have been looking at stock status since May 13th. After legislation of July 10th, there was a state of chaos. What I have subsequently observed is that the flower medicine of different brands sold out and quickly came back in stock. But as the days went by, I could see that more and more online stores reported sold out, and the flowers did not come back in stock. I wondered about it, but I didn't think much more about it. (It wasn't the flower medicine I was keeping an eye on) It was only after July 29th, when it was announced that the flower medicine had its subsidy withdrawn, that the penny dropped. The German users have naturally hoarded flower medicine, just in case the politicians were serious about it. Those people who were proactive could manage to build up a private stock for at least 6 months' consumption. It has been a blessing in disguise for Stenocare that some of these 65,000 people, who now have to be converted to another product, have hoarded flower medicine. The misfortune consists in that those people who had not hoarded flower medicine, after July 30th, received a prescription for an oil preparation, including Weeco Astrum 10/10, and thereby a greater demand was created, which has led to bottlenecks. Because it all happened within a short period of time, neither Stenocare nor Weeco Pharma could react in time. Germany has very strict legislation regarding cannabis medicine, and that also applies to how much cannabis medicine one is allowed to have in stock. Therefore, it has not been possible for Weeco Pharma to build up a stock, in case this scenario should happen. The fortunate thing is that some people hoarded flower medicine before July 30th, and therefore not all 65,000 users have to be converted to another preparation within a very short period of time, and Germany would thus be completely drained of Weeco Astrum 10/10. I think that both Weeco Pharma and Stenocare have discovered the increased demand, and that more bottles are now being sent than were previously sent to Germany. To ensure that there is oil for everyone, as people's home stocks become empty, and they get a prescription for Weeco Astrum 10/10.Today's figures increase in number of trades 612% the price 0.932 kr. and the price has increased by 3.72%.
- ·1 päivä sittenIt seems some have tried to sell off a lot this past week, not least 100,000 units today. Can anyone see who is selling?
- ·2 päivää sittenStock status Canngo: 2 pharmacies in Dusseldorf have bought the oil internally, and therefore have Weeco Astrum 10/10 back in stock. Weeco Pharma has not succeeded in getting a new batch approved, so they can restock the empty shelves again. I hope that will happen soon.I came across this article that has put numbers on how many people have lost their subsidy for flower medicine in Germany as of July 30. The article states 65,000 people. Although not all of them are prescribed Weeco Astrum 10/10, we can conclude that some of these people have received a prescription for Weeco Astrum 10/10 and this demand has led to bottlenecks in the delivery of the oil. Everyone who starts using Weeco Astrum 10/10 and it works as it should, will typically buy 4-6 bottles per year. https://internationalcbc.com/how-many-german-patients-are-impacted-by-cannabis-flower-changes/
- ·3 päivää sittenI have started doing deeper analysis coverage on the STENOCARE case, which I share via my new Substack (frees up space for the thread here, which from time to time becomes somewhat messy and unserious). Latest post – "STENOCARE: From growth case to maturity plateau – what Q1/Q2 data and the 14-day rates reveal before the Q2 report" – is located here: 👉 https://xcapitalinvestor.substack.com/p/stenocare-fra-vkstcase-til-modenhedsplateau The format is new to me, so feedback is very welcome – both on content and whether it creates value for you. Happy Monday ☕By the way, it's good that cash flow has developed positively, although the surplus is minimal. In that regard, the price pressure is a bit worrying (8% down, that is, so far). It won't take much further headwind before cash flow is red again, and purely financially, it's not as if Steno exactly has much to draw upon.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. | 7 päivää |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
2026 Q1 -tulosraportti
Vain PDF
98 päivää sitten
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. | 7 päivää |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·2 t sitten · MuokattuStock status Everything is status quo, so we can conclude that it has not yet been possible to get the oil into Germany. But as long as Germany is not completely dry, people can get hold of the oil when they get a prescription. The following is on my bill. I'm crossing my fingers that Weeco Pharma will manage to get the oil into Germany before the people who have hoarded a small stock of flower medicine privately run out. The people who hoarded this summer have been able to buy 100 grams per month. Around 200 grams in total. How long will it take them to smoke/vape 200 grams of cannabis 2-3 months? As these stocks run out, they will go to their doctor to get a prescription for an alternative cannabis medicine to the flower medicine. Weeco Astrum 10/10 is not affected by a 6-month quarantine, and the product has retained 100% reimbursement, and therefore doctors can calmly (the feared Regress system) prescribe Weeco Astrum 10/10 to patients where doctors assess that they should have a prescription for Weeco Astrum 10/10. If my little unscientific calculation is correct, Weeco Pharma has a couple of months to run on, so I guess they will make it. It says approximately in the middle of the article and under the heading How exactly is cannabis prescribed? https://www.aerzteblatt.de/archiv/medizinisches-cannabis-die-wichtigsten-aenderungen-8947932a-bc22-401b-a928-ee432de6bc59I just have an addition to the above. It occurred to me that I have read somewhere that it was also changed that people now have to meet with their general practitioner to get a prescription for medical cannabis. Telemedicine is forbidden (if I have understood it correctly, it is a complicated topic) A maximum of (at most) 3 months may pass before a doctor sees their patient with a chronic illness, which again means that the doctor may at most prescribe a prescription for medical cannabis that lasts for 3 months. Previously, they could prescribe a prescription for Weeco Astrum 10/10 2 bottles of 30 ml. and people typically bought 2 bottles at a time. They can no longer do that, when one bottle typically lasts 2-3 months. https://www.hausaerztlichepraxis.digital/praxis/medikamente-fuer-mehrere-monate-auf-rezept-moeglich-127970.html
- ·1 päivä sittenstock status All is status quo, but I can see that the pharmacy in Hamburg has many in stock, (dark green dot) but the pharmacy in Dusseldorf has few in stock. (light green dot) However, I cannot see the quantity. Bonus information As is known, I have been looking at stock status since May 13th. After legislation of July 10th, there was a state of chaos. What I have subsequently observed is that the flower medicine of different brands sold out and quickly came back in stock. But as the days went by, I could see that more and more online stores reported sold out, and the flowers did not come back in stock. I wondered about it, but I didn't think much more about it. (It wasn't the flower medicine I was keeping an eye on) It was only after July 29th, when it was announced that the flower medicine had its subsidy withdrawn, that the penny dropped. The German users have naturally hoarded flower medicine, just in case the politicians were serious about it. Those people who were proactive could manage to build up a private stock for at least 6 months' consumption. It has been a blessing in disguise for Stenocare that some of these 65,000 people, who now have to be converted to another product, have hoarded flower medicine. The misfortune consists in that those people who had not hoarded flower medicine, after July 30th, received a prescription for an oil preparation, including Weeco Astrum 10/10, and thereby a greater demand was created, which has led to bottlenecks. Because it all happened within a short period of time, neither Stenocare nor Weeco Pharma could react in time. Germany has very strict legislation regarding cannabis medicine, and that also applies to how much cannabis medicine one is allowed to have in stock. Therefore, it has not been possible for Weeco Pharma to build up a stock, in case this scenario should happen. The fortunate thing is that some people hoarded flower medicine before July 30th, and therefore not all 65,000 users have to be converted to another preparation within a very short period of time, and Germany would thus be completely drained of Weeco Astrum 10/10. I think that both Weeco Pharma and Stenocare have discovered the increased demand, and that more bottles are now being sent than were previously sent to Germany. To ensure that there is oil for everyone, as people's home stocks become empty, and they get a prescription for Weeco Astrum 10/10.Today's figures increase in number of trades 612% the price 0.932 kr. and the price has increased by 3.72%.
- ·1 päivä sittenIt seems some have tried to sell off a lot this past week, not least 100,000 units today. Can anyone see who is selling?
- ·2 päivää sittenStock status Canngo: 2 pharmacies in Dusseldorf have bought the oil internally, and therefore have Weeco Astrum 10/10 back in stock. Weeco Pharma has not succeeded in getting a new batch approved, so they can restock the empty shelves again. I hope that will happen soon.I came across this article that has put numbers on how many people have lost their subsidy for flower medicine in Germany as of July 30. The article states 65,000 people. Although not all of them are prescribed Weeco Astrum 10/10, we can conclude that some of these people have received a prescription for Weeco Astrum 10/10 and this demand has led to bottlenecks in the delivery of the oil. Everyone who starts using Weeco Astrum 10/10 and it works as it should, will typically buy 4-6 bottles per year. https://internationalcbc.com/how-many-german-patients-are-impacted-by-cannabis-flower-changes/
- ·3 päivää sittenI have started doing deeper analysis coverage on the STENOCARE case, which I share via my new Substack (frees up space for the thread here, which from time to time becomes somewhat messy and unserious). Latest post – "STENOCARE: From growth case to maturity plateau – what Q1/Q2 data and the 14-day rates reveal before the Q2 report" – is located here: 👉 https://xcapitalinvestor.substack.com/p/stenocare-fra-vkstcase-til-modenhedsplateau The format is new to me, so feedback is very welcome – both on content and whether it creates value for you. Happy Monday ☕By the way, it's good that cash flow has developed positively, although the surplus is minimal. In that regard, the price pressure is a bit worrying (8% down, that is, so far). It won't take much further headwind before cash flow is red again, and purely financially, it's not as if Steno exactly has much to draw upon.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt